कुल 50 हाल के अंदरूनी लेनदेन दर्ज हैं Apellis Pharmaceuticals, Inc. (APLS), जिसमें शामिल हैं 17 खरीद और 30 बिक्री. कुल अंदरूनी खरीद मूल्य $2.58M और कुल अंदरूनी बिक्री मूल्य $3.11M.
हाल की गतिविधि वाले उल्लेखनीय अंदरूनी लोगों में शामिल हैं Biogen Inc., Francois Cedric, Dolsten Mikael. अंदरूनी लेनदेन से पता चल सकता है कि कंपनी का नेतृत्व स्टॉक के मूल्यांकन और भविष्य की संभावनाओं को कैसे देखता है.
इनसाइडर ट्रेडिंग — APLS
| तिथि |
नाम |
भूमिका |
लेनदेन प्रकार |
शेयर |
औसत मूल्य |
मूल्य |
स्वामित्व वाले शेयर |
| 2026-03-31 |
Biogen Inc. |
Other: See Footnotes |
अज्ञात |
- |
- |
- |
- |
| 2026-03-11 |
Francois Cedric |
Chief Executive Officer |
उपहार (प्राप्त) |
64,869 |
- |
- |
372,815 |
| 2026-03-02 |
Dolsten Mikael |
Director |
अज्ञात |
- |
- |
- |
- |
| 2026-02-27 |
Dolsten Mikael |
Director |
RSU पुरस्कार |
14,312 |
- |
- |
14,312 |
| 2026-02-11 |
Delong Mark Jeffrey |
Chief Business & Strat Officer |
सूचित बिक्री |
368 |
$22.15 |
$8.15K |
114,591 |
| 2026-02-03 |
Francois Cedric |
Chief Executive Officer |
विकल्प प्रयोग (बिक्री) |
8,840 |
$3.76 |
$33.24K |
- |
| 2026-01-28 |
Watson David O. |
General Counsel |
RSU पुरस्कार |
55,986 |
- |
- |
144,517 |
| 2026-01-28 |
Deschatelets Pascal |
Chief Scientific Officer |
RSU पुरस्कार |
25,840 |
- |
- |
1,177,222 |
| 2026-01-28 |
Francois Cedric |
Chief Executive Officer |
RSU पुरस्कार |
195,952 |
- |
- |
481,997 |
| 2026-01-28 |
Sullivan Timothy Eugene |
Chief Financial Officer |
RSU पुरस्कार |
58,140 |
- |
- |
152,041 |
| 2026-01-28 |
Nicholson Nur |
Chief Technical Officer |
RSU पुरस्कार |
45,220 |
- |
- |
116,338 |
| 2026-01-28 |
Chopas James George |
VP/chief Accounting Officer |
RSU पुरस्कार |
16,150 |
- |
- |
65,955 |
| 2026-01-28 |
Delong Mark Jeffrey |
Chief Business & Strat Officer |
RSU पुरस्कार |
36,606 |
- |
- |
114,959 |
| 2026-01-28 |
Boucher Kelley |
Chief People Officer |
RSU पुरस्कार |
30,146 |
- |
- |
127,804 |
| 2026-01-28 |
Meltzer Leslie |
Chief Research and Development |
RSU पुरस्कार |
45,220 |
- |
- |
107,024 |
| 2026-01-22 |
Watson David O. |
General Counsel |
सूचित बिक्री |
7,832 |
$21.77 |
$170.47K |
88,531 |
| 2026-01-22 |
Deschatelets Pascal |
Chief Scientific Officer |
सूचित बिक्री |
5,928 |
$21.77 |
$129.03K |
1,151,382 |
| 2026-01-22 |
Francois Cedric |
Chief Executive Officer |
सूचित बिक्री |
27,192 |
$21.77 |
$591.84K |
286,045 |
| 2026-01-22 |
Sullivan Timothy Eugene |
Chief Financial Officer |
सूचित बिक्री |
10,287 |
$21.77 |
$223.9K |
93,901 |
| 2026-01-22 |
Nicholson Nur |
Chief Technical Officer |
सूचित बिक्री |
7,725 |
$21.77 |
$168.14K |
71,118 |
| 2026-01-22 |
Chopas James George |
VP/chief Accounting Officer |
सूचित बिक्री |
2,064 |
$21.77 |
$44.92K |
49,805 |
| 2026-01-22 |
Delong Mark Jeffrey |
Chief Business & Strat Officer |
सूचित बिक्री |
3,371 |
$21.77 |
$73.37K |
78,353 |
| 2026-01-22 |
Baumal Caroline |
Chief Medical Officer |
सूचित बिक्री |
2,797 |
$21.77 |
$60.88K |
86,527 |
| 2026-01-20 |
Watson David O. |
General Counsel |
सूचित बिक्री |
2,475 |
$19.79 |
$48.99K |
96,363 |
| 2026-01-20 |
Deschatelets Pascal |
Chief Scientific Officer |
सूचित बिक्री |
909 |
$19.79 |
$17.99K |
1,157,310 |
| 2026-01-20 |
Francois Cedric |
Chief Executive Officer |
सूचित बिक्री |
8,182 |
$19.79 |
$161.95K |
313,237 |
| 2026-01-20 |
Sullivan Timothy Eugene |
Chief Financial Officer |
सूचित बिक्री |
2,892 |
$19.79 |
$57.24K |
104,188 |
| 2026-01-20 |
Nicholson Nur |
Chief Technical Officer |
सूचित बिक्री |
2,203 |
$19.79 |
$43.6K |
78,843 |
| 2026-01-20 |
Chopas James George |
VP/chief Accounting Officer |
सूचित बिक्री |
726 |
$19.79 |
$14.37K |
51,869 |
| 2026-01-20 |
Delong Mark Jeffrey |
Chief Business & Strat Officer |
सूचित बिक्री |
1,334 |
$19.79 |
$26.4K |
81,724 |
| 2026-01-20 |
Baumal Caroline |
Chief Medical Officer |
सूचित बिक्री |
1,882 |
$19.79 |
$37.25K |
89,324 |
| 2026-01-13 |
Watson David O. |
General Counsel |
सूचित बिक्री |
5,780 |
$22.19 |
$128.24K |
98,838 |
| 2026-01-13 |
Deschatelets Pascal |
Chief Scientific Officer |
सूचित बिक्री |
2,277 |
$22.19 |
$50.52K |
1,158,219 |
| 2026-01-13 |
Francois Cedric |
Chief Executive Officer |
सूचित बिक्री |
10,186 |
$22.19 |
$226K |
321,419 |
| 2026-01-13 |
Sullivan Timothy Eugene |
Chief Financial Officer |
सूचित बिक्री |
3,856 |
$22.19 |
$85.55K |
107,080 |
| 2026-01-13 |
Nicholson Nur |
Chief Technical Officer |
सूचित बिक्री |
2,618 |
$22.19 |
$58.09K |
81,046 |
| 2026-01-13 |
Chopas James George |
VP/chief Accounting Officer |
सूचित बिक्री |
873 |
$22.19 |
$19.37K |
52,595 |
| 2026-01-13 |
Delong Mark Jeffrey |
Chief Business & Strat Officer |
सूचित बिक्री |
1,780 |
$22.19 |
$39.49K |
83,058 |
| 2026-01-07 |
Watson David O. |
General Counsel |
विकल्प प्रयोग (बिक्री) |
888 |
$14.95 |
$13.28K |
14,000 |
| 2026-01-05 |
Baumal Caroline |
Chief Medical Officer |
सूचित बिक्री |
3,020 |
$25.53 |
$77.1K |
91,206 |
| 2026-01-01 |
Wheeler Craig A |
Director |
RSU पुरस्कार |
14,684 |
$25.12 |
$368.86K |
14,684 |
| 2026-01-01 |
Machiels Alec |
Director |
RSU पुरस्कार |
14,684 |
$25.12 |
$368.86K |
14,684 |
| 2026-01-01 |
Chan Gerald |
Director |
RSU पुरस्कार |
14,684 |
$25.12 |
$368.86K |
14,684 |
| 2026-01-01 |
O'brien Stephanie Monaghan |
Director |
RSU पुरस्कार |
14,684 |
$25.12 |
$368.86K |
14,684 |
| 2026-01-01 |
Dunlop A. Sinclair |
Director |
RSU पुरस्कार |
14,684 |
$25.12 |
$368.86K |
14,684 |
| 2026-01-01 |
Fonteyne Paul R. |
Director |
RSU पुरस्कार |
14,684 |
$25.12 |
$368.86K |
14,684 |
| 2026-01-01 |
Walbert Keli |
Director |
RSU पुरस्कार |
14,684 |
$25.12 |
$368.86K |
14,684 |
| 2025-12-16 |
Watson David O. |
General Counsel |
सूचित बिक्री |
5,000 |
$24.49 |
$122.45K |
103,730 |
| 2025-11-17 |
Watson David O. |
General Counsel |
सूचित बिक्री |
5,000 |
$20.06 |
$100.3K |
108,730 |
| 2025-10-21 |
Sullivan Timothy Eugene |
Chief Financial Officer |
सूचित बिक्री |
10,000 |
$28.03 |
$280.3K |
110,936 |
■ जानकारीपूर्ण — खुले बाजार में खरीद/बिक्री (सर्वाधिक महत्वपूर्ण)
■ गैर-जानकारी खरीद — पुरस्कार, विकल्प अभ्यास, रूपांतरण
■ गैर-जानकारी बिक्री — कर रोक, पुरस्कार बिक्री
■ तटस्थ — उपहार, ट्रस्ट, समाप्ति